Financhill
Buy
62

DSRLF Quote, Financials, Valuation and Earnings

Last price:
$109.6000
Seasonality move :
8.57%
Day range:
$109.6000 - $109.6000
52-week range:
$88.4500 - $109.6000
Dividend yield:
1.14%
P/E ratio:
28.54x
P/S ratio:
4.57x
P/B ratio:
3.41x
Volume:
--
Avg. volume:
6
1-year change:
18.85%
Market cap:
$5.9B
Revenue:
$1.3B
EPS (TTM):
$3.84

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
DSRLF
Diasorin SpA
-- -- -- -- --
ELEAF
El.En. SpA
-- -- -- -- --
GNTA
Genenta Science SPA
-- -- -- -- --
RICFY
Recordati SpA
-- -- -- -- --
SAFLF
Safilo Group SpA
-- -- -- -- --
STVN
Stevanato Group SpA
$294.9M $0.12 5% 29.39% $26.84
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
DSRLF
Diasorin SpA
$109.6000 -- $5.9B 28.54x $1.25 1.14% 4.57x
ELEAF
El.En. SpA
$9.80 -- $784.7M 17.81x $0.22 2.22% 1.26x
GNTA
Genenta Science SPA
$3.97 -- $72.6M -- $0.00 0% --
RICFY
Recordati SpA
$14.51 -- $12B 26.88x $0.16 2.26% 4.79x
SAFLF
Safilo Group SpA
$0.9500 -- $383.1M 16.68x $0.00 0% 0.37x
STVN
Stevanato Group SpA
$20.29 $26.84 $5.5B 42.71x $0.06 0.29% 4.61x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
DSRLF
Diasorin SpA
37.14% -0.837 -- 1.67x
ELEAF
El.En. SpA
10.22% 0.000 6.2% 1.76x
GNTA
Genenta Science SPA
-- -0.046 -- --
RICFY
Recordati SpA
56.97% 0.267 23.73% 1.02x
SAFLF
Safilo Group SpA
17.52% -0.153 22.25% 0.93x
STVN
Stevanato Group SpA
22.69% -0.033 7.21% 1.32x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
DSRLF
Diasorin SpA
$206.8M $69.3M 9.02% 10.8% 21.95% $217.9M
ELEAF
El.En. SpA
$66.8M $29.2M 9.09% 10.5% 25.77% $16.1M
GNTA
Genenta Science SPA
-- -- -- -- -- --
RICFY
Recordati SpA
$440.6M $135.9M 11.4% 23.01% 22.97% -$763.6M
SAFLF
Safilo Group SpA
-- -- 4.3% 5.38% -- --
STVN
Stevanato Group SpA
$104.6M $71.3M 7.08% 9.13% 20.45% $39.5M

Diasorin SpA vs. Competitors

  • Which has Higher Returns DSRLF or ELEAF?

    El.En. SpA has a net margin of 15.68% compared to Diasorin SpA's net margin of -2.06%. Diasorin SpA's return on equity of 10.8% beat El.En. SpA's return on equity of 10.5%.

    Company Gross Margin Earnings Per Share Invested Capital
    DSRLF
    Diasorin SpA
    65.51% $0.93 $2.8B
    ELEAF
    El.En. SpA
    58.85% -$0.03 $476.1M
  • What do Analysts Say About DSRLF or ELEAF?

    Diasorin SpA has a consensus price target of --, signalling downside risk potential of --. On the other hand El.En. SpA has an analysts' consensus of -- which suggests that it could fall by --. Given that Diasorin SpA has higher upside potential than El.En. SpA, analysts believe Diasorin SpA is more attractive than El.En. SpA.

    Company Buy Ratings Hold Ratings Sell Ratings
    DSRLF
    Diasorin SpA
    0 0 0
    ELEAF
    El.En. SpA
    0 0 0
  • Is DSRLF or ELEAF More Risky?

    Diasorin SpA has a beta of 0.178, which suggesting that the stock is 82.244% less volatile than S&P 500. In comparison El.En. SpA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DSRLF or ELEAF?

    Diasorin SpA has a quarterly dividend of $1.25 per share corresponding to a yield of 1.14%. El.En. SpA offers a yield of 2.22% to investors and pays a quarterly dividend of $0.22 per share. Diasorin SpA pays -- of its earnings as a dividend. El.En. SpA pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DSRLF or ELEAF?

    Diasorin SpA quarterly revenues are $315.6M, which are larger than El.En. SpA quarterly revenues of $113.5M. Diasorin SpA's net income of $49.5M is higher than El.En. SpA's net income of -$2.3M. Notably, Diasorin SpA's price-to-earnings ratio is 28.54x while El.En. SpA's PE ratio is 17.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Diasorin SpA is 4.57x versus 1.26x for El.En. SpA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DSRLF
    Diasorin SpA
    4.57x 28.54x $315.6M $49.5M
    ELEAF
    El.En. SpA
    1.26x 17.81x $113.5M -$2.3M
  • Which has Higher Returns DSRLF or GNTA?

    Genenta Science SPA has a net margin of 15.68% compared to Diasorin SpA's net margin of --. Diasorin SpA's return on equity of 10.8% beat Genenta Science SPA's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    DSRLF
    Diasorin SpA
    65.51% $0.93 $2.8B
    GNTA
    Genenta Science SPA
    -- -- --
  • What do Analysts Say About DSRLF or GNTA?

    Diasorin SpA has a consensus price target of --, signalling downside risk potential of --. On the other hand Genenta Science SPA has an analysts' consensus of -- which suggests that it could grow by 479.65%. Given that Genenta Science SPA has higher upside potential than Diasorin SpA, analysts believe Genenta Science SPA is more attractive than Diasorin SpA.

    Company Buy Ratings Hold Ratings Sell Ratings
    DSRLF
    Diasorin SpA
    0 0 0
    GNTA
    Genenta Science SPA
    0 0 0
  • Is DSRLF or GNTA More Risky?

    Diasorin SpA has a beta of 0.178, which suggesting that the stock is 82.244% less volatile than S&P 500. In comparison Genenta Science SPA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DSRLF or GNTA?

    Diasorin SpA has a quarterly dividend of $1.25 per share corresponding to a yield of 1.14%. Genenta Science SPA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Diasorin SpA pays -- of its earnings as a dividend. Genenta Science SPA pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DSRLF or GNTA?

    Diasorin SpA quarterly revenues are $315.6M, which are larger than Genenta Science SPA quarterly revenues of --. Diasorin SpA's net income of $49.5M is higher than Genenta Science SPA's net income of --. Notably, Diasorin SpA's price-to-earnings ratio is 28.54x while Genenta Science SPA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Diasorin SpA is 4.57x versus -- for Genenta Science SPA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DSRLF
    Diasorin SpA
    4.57x 28.54x $315.6M $49.5M
    GNTA
    Genenta Science SPA
    -- -- -- --
  • Which has Higher Returns DSRLF or RICFY?

    Recordati SpA has a net margin of 15.68% compared to Diasorin SpA's net margin of 13.05%. Diasorin SpA's return on equity of 10.8% beat Recordati SpA's return on equity of 23.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    DSRLF
    Diasorin SpA
    65.51% $0.93 $2.8B
    RICFY
    Recordati SpA
    69.07% $0.10 $4.5B
  • What do Analysts Say About DSRLF or RICFY?

    Diasorin SpA has a consensus price target of --, signalling downside risk potential of --. On the other hand Recordati SpA has an analysts' consensus of -- which suggests that it could fall by --. Given that Diasorin SpA has higher upside potential than Recordati SpA, analysts believe Diasorin SpA is more attractive than Recordati SpA.

    Company Buy Ratings Hold Ratings Sell Ratings
    DSRLF
    Diasorin SpA
    0 0 0
    RICFY
    Recordati SpA
    0 0 0
  • Is DSRLF or RICFY More Risky?

    Diasorin SpA has a beta of 0.178, which suggesting that the stock is 82.244% less volatile than S&P 500. In comparison Recordati SpA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DSRLF or RICFY?

    Diasorin SpA has a quarterly dividend of $1.25 per share corresponding to a yield of 1.14%. Recordati SpA offers a yield of 2.26% to investors and pays a quarterly dividend of $0.16 per share. Diasorin SpA pays -- of its earnings as a dividend. Recordati SpA pays out 60.92% of its earnings as a dividend. Recordati SpA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios DSRLF or RICFY?

    Diasorin SpA quarterly revenues are $315.6M, which are smaller than Recordati SpA quarterly revenues of $637.9M. Diasorin SpA's net income of $49.5M is lower than Recordati SpA's net income of $83.3M. Notably, Diasorin SpA's price-to-earnings ratio is 28.54x while Recordati SpA's PE ratio is 26.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Diasorin SpA is 4.57x versus 4.79x for Recordati SpA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DSRLF
    Diasorin SpA
    4.57x 28.54x $315.6M $49.5M
    RICFY
    Recordati SpA
    4.79x 26.88x $637.9M $83.3M
  • Which has Higher Returns DSRLF or SAFLF?

    Safilo Group SpA has a net margin of 15.68% compared to Diasorin SpA's net margin of --. Diasorin SpA's return on equity of 10.8% beat Safilo Group SpA's return on equity of 5.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    DSRLF
    Diasorin SpA
    65.51% $0.93 $2.8B
    SAFLF
    Safilo Group SpA
    -- -- $536.1M
  • What do Analysts Say About DSRLF or SAFLF?

    Diasorin SpA has a consensus price target of --, signalling downside risk potential of --. On the other hand Safilo Group SpA has an analysts' consensus of -- which suggests that it could fall by --. Given that Diasorin SpA has higher upside potential than Safilo Group SpA, analysts believe Diasorin SpA is more attractive than Safilo Group SpA.

    Company Buy Ratings Hold Ratings Sell Ratings
    DSRLF
    Diasorin SpA
    0 0 0
    SAFLF
    Safilo Group SpA
    0 0 0
  • Is DSRLF or SAFLF More Risky?

    Diasorin SpA has a beta of 0.178, which suggesting that the stock is 82.244% less volatile than S&P 500. In comparison Safilo Group SpA has a beta of -69.335, suggesting its less volatile than the S&P 500 by 7033.488%.

  • Which is a Better Dividend Stock DSRLF or SAFLF?

    Diasorin SpA has a quarterly dividend of $1.25 per share corresponding to a yield of 1.14%. Safilo Group SpA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Diasorin SpA pays -- of its earnings as a dividend. Safilo Group SpA pays out 3.42% of its earnings as a dividend. Safilo Group SpA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios DSRLF or SAFLF?

    Diasorin SpA quarterly revenues are $315.6M, which are larger than Safilo Group SpA quarterly revenues of --. Diasorin SpA's net income of $49.5M is higher than Safilo Group SpA's net income of --. Notably, Diasorin SpA's price-to-earnings ratio is 28.54x while Safilo Group SpA's PE ratio is 16.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Diasorin SpA is 4.57x versus 0.37x for Safilo Group SpA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DSRLF
    Diasorin SpA
    4.57x 28.54x $315.6M $49.5M
    SAFLF
    Safilo Group SpA
    0.37x 16.68x -- --
  • Which has Higher Returns DSRLF or STVN?

    Stevanato Group SpA has a net margin of 15.68% compared to Diasorin SpA's net margin of 14.61%. Diasorin SpA's return on equity of 10.8% beat Stevanato Group SpA's return on equity of 9.13%.

    Company Gross Margin Earnings Per Share Invested Capital
    DSRLF
    Diasorin SpA
    65.51% $0.93 $2.8B
    STVN
    Stevanato Group SpA
    29.69% $0.19 $1.9B
  • What do Analysts Say About DSRLF or STVN?

    Diasorin SpA has a consensus price target of --, signalling downside risk potential of --. On the other hand Stevanato Group SpA has an analysts' consensus of $26.84 which suggests that it could grow by 32.29%. Given that Stevanato Group SpA has higher upside potential than Diasorin SpA, analysts believe Stevanato Group SpA is more attractive than Diasorin SpA.

    Company Buy Ratings Hold Ratings Sell Ratings
    DSRLF
    Diasorin SpA
    0 0 0
    STVN
    Stevanato Group SpA
    5 3 0
  • Is DSRLF or STVN More Risky?

    Diasorin SpA has a beta of 0.178, which suggesting that the stock is 82.244% less volatile than S&P 500. In comparison Stevanato Group SpA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DSRLF or STVN?

    Diasorin SpA has a quarterly dividend of $1.25 per share corresponding to a yield of 1.14%. Stevanato Group SpA offers a yield of 0.29% to investors and pays a quarterly dividend of $0.06 per share. Diasorin SpA pays -- of its earnings as a dividend. Stevanato Group SpA pays out 12.28% of its earnings as a dividend. Stevanato Group SpA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios DSRLF or STVN?

    Diasorin SpA quarterly revenues are $315.6M, which are smaller than Stevanato Group SpA quarterly revenues of $352.4M. Diasorin SpA's net income of $49.5M is lower than Stevanato Group SpA's net income of $51.5M. Notably, Diasorin SpA's price-to-earnings ratio is 28.54x while Stevanato Group SpA's PE ratio is 42.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Diasorin SpA is 4.57x versus 4.61x for Stevanato Group SpA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DSRLF
    Diasorin SpA
    4.57x 28.54x $315.6M $49.5M
    STVN
    Stevanato Group SpA
    4.61x 42.71x $352.4M $51.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Why Did Buffett Sell the S&P 500?
Why Did Buffett Sell the S&P 500?

Warren Buffett has always been an advocate of investing in…

Will SoundHound AI Stock Recover?
Will SoundHound AI Stock Recover?

SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

Sell
24
AIR alert for Mar 29

AAR [AIR] is down 16.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock